Revelation Capital Stock vs Cash And Short Term Investments Analysis

REVBW Stock  USD 0.02  0.0009  4.81%   
Revelation Biosciences financial indicator trend analysis is much more than just breaking down Revelation Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Revelation Biosciences is a good investment. Please check the relationship between Revelation Biosciences Capital Stock and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.

Capital Stock vs Cash And Short Term Investments

Capital Stock vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Revelation Biosciences Capital Stock account and Cash And Short Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Revelation Biosciences' Capital Stock and Cash And Short Term Investments is -0.41. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Revelation Biosciences, assuming nothing else is changed. The correlation between historical values of Revelation Biosciences' Capital Stock and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Revelation Biosciences are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Capital Stock i.e., Revelation Biosciences' Capital Stock and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.41
Relationship DirectionNegative 
Relationship StrengthVery Weak

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Revelation Biosciences balance sheet. This account contains Revelation Biosciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Revelation Biosciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Revelation Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Revelation Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.Selling General Administrative is likely to drop to about 4.2 M in 2025. Issuance Of Capital Stock is likely to drop to about 12.4 M in 2025
 2022 2023 2024 2025 (projected)
Reconciled Depreciation25.0K25.0K28.8K24.5K
Cost Of Revenue40.0K25.0K22.5K35.8K

Revelation Biosciences fundamental ratios Correlations

0.950.970.98-0.870.060.060.950.97-0.890.620.920.92-0.76-0.940.040.890.530.93-0.150.73-0.94-0.760.93-0.76
0.950.990.86-0.97-0.12-0.120.880.99-0.80.460.840.84-0.69-0.980.10.950.380.85-0.060.55-0.98-0.690.98-0.69
0.970.990.9-0.96-0.05-0.050.91.0-0.810.490.850.85-0.71-0.970.120.940.390.86-0.050.58-0.97-0.710.97-0.71
0.980.860.9-0.760.160.160.960.9-0.910.710.940.94-0.76-0.87-0.030.80.630.95-0.240.82-0.88-0.760.86-0.76
-0.87-0.97-0.96-0.760.110.11-0.76-0.960.68-0.35-0.69-0.690.520.93-0.22-0.95-0.18-0.71-0.09-0.360.930.52-0.930.52
0.06-0.12-0.050.160.111.0-0.13-0.050.1-0.05-0.11-0.110.090.15-0.07-0.160.0-0.11-0.05-0.050.150.09-0.150.09
0.06-0.12-0.050.160.111.0-0.12-0.050.1-0.05-0.11-0.110.090.15-0.07-0.160.0-0.11-0.05-0.050.150.09-0.150.09
0.950.880.90.96-0.76-0.13-0.120.9-0.940.740.980.98-0.8-0.890.010.820.640.98-0.210.86-0.9-0.80.87-0.8
0.970.991.00.9-0.96-0.05-0.050.9-0.810.490.850.85-0.71-0.970.120.940.390.86-0.050.58-0.97-0.710.97-0.71
-0.89-0.8-0.81-0.910.680.10.1-0.94-0.81-0.81-0.97-0.970.630.880.29-0.78-0.8-0.970.48-0.90.890.63-0.850.63
0.620.460.490.71-0.35-0.05-0.050.740.49-0.810.760.76-0.35-0.54-0.250.580.710.75-0.390.83-0.55-0.350.49-0.35
0.920.840.850.94-0.69-0.11-0.110.980.85-0.970.761.0-0.8-0.89-0.210.770.781.0-0.410.92-0.89-0.80.87-0.8
0.920.840.850.94-0.69-0.11-0.110.980.85-0.970.761.0-0.8-0.89-0.210.770.781.0-0.410.92-0.89-0.80.87-0.8
-0.76-0.69-0.71-0.760.520.090.09-0.8-0.710.63-0.35-0.8-0.80.65-0.05-0.49-0.52-0.80.15-0.710.661.0-0.691.0
-0.94-0.98-0.97-0.870.930.150.15-0.89-0.970.88-0.54-0.89-0.890.650.08-0.94-0.52-0.890.25-0.641.00.65-1.00.65
0.040.10.12-0.03-0.22-0.07-0.070.010.120.29-0.25-0.21-0.21-0.050.080.09-0.73-0.170.97-0.360.08-0.05-0.09-0.05
0.890.950.940.8-0.95-0.16-0.160.820.94-0.780.580.770.77-0.49-0.940.090.330.78-0.040.49-0.94-0.490.93-0.49
0.530.380.390.63-0.180.00.00.640.39-0.80.710.780.78-0.52-0.52-0.730.330.76-0.860.9-0.53-0.520.51-0.52
0.930.850.860.95-0.71-0.11-0.110.980.86-0.970.751.01.0-0.8-0.89-0.170.780.76-0.380.91-0.9-0.80.88-0.8
-0.15-0.06-0.05-0.24-0.09-0.05-0.05-0.21-0.050.48-0.39-0.41-0.410.150.250.97-0.04-0.86-0.38-0.560.250.15-0.250.15
0.730.550.580.82-0.36-0.05-0.050.860.58-0.90.830.920.92-0.71-0.64-0.360.490.90.91-0.56-0.65-0.710.62-0.71
-0.94-0.98-0.97-0.880.930.150.15-0.9-0.970.89-0.55-0.89-0.890.661.00.08-0.94-0.53-0.90.25-0.650.66-1.00.66
-0.76-0.69-0.71-0.760.520.090.09-0.8-0.710.63-0.35-0.8-0.81.00.65-0.05-0.49-0.52-0.80.15-0.710.66-0.691.0
0.930.980.970.86-0.93-0.15-0.150.870.97-0.850.490.870.87-0.69-1.0-0.090.930.510.88-0.250.62-1.0-0.69-0.69
-0.76-0.69-0.71-0.760.520.090.09-0.8-0.710.63-0.35-0.8-0.81.00.65-0.05-0.49-0.52-0.80.15-0.710.661.0-0.69
Click cells to compare fundamentals

Revelation Biosciences Account Relationship Matchups

Revelation Biosciences fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets4.6M2.0M5.5M12.2M14.0M14.7M
Other Current Liab342.9K1.5M3.9M4.2M4.8M5.1M
Total Current Liabilities1.2M2.1M4.5M5.6M6.4M6.7M
Total Stockholder Equity3.4M(99.5K)1.1M6.6M7.6M8.0M
Retained Earnings(2.5M)(14.5M)(25.3M)(25.5M)(22.9M)(21.8M)
Non Current Assets Total73.5M130.1K90.1K65.1K58.6K55.6K
Liabilities And Stockholders Equity4.6M2.0M5.5M12.2M14.0M14.7M
Total Liab1.2M2.1M4.5M5.6M6.4M6.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.